SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DePhyneAI is a decentralized physical AI infrastructure enabling autonomous devices such as drones, robots, and edge sensors to perform intelligent tasks while earning rewards in the native token, $DPHY. The network is permissionless, community-owned, and designed to bring scalable, secure AI computation to the edge of the real world.  1. Introduction Artificial Intelligence has historically been confined to centralized cloud platforms. However, as physical devices grow more capable, the future lies in enabling intelligence directly on the edge - embedded in the real world. DePhyneAI empowers a decentralized network of autonomous agents to train, infer, and collaborate - creating a self-sustaining AI ecosystem governed by a native token economy.  What is DePhyneAI? DePhyneAI is an open, decentralized network where physical devices act as nodes. Each device contributes compute, data, or services and is rewarded in $DPHY tokens. The network supports:  Federated learning and on-device AI inference Secure blockchain-based coordination Real-time decision-making in physical environments Use Cases DePhyneAI supports diverse real-world applications:  Logistics: AI-enabled autonomous drone deliveries Agriculture: Monitoring soil, crop health, irrigation using robotic systems Smart Cities: Surveillance, traffic analysis, energy optimization Disaster Response: Real-time aerial monitoring and situational AI Why $DPHY Matters The $DPHY token is the lifeblood of the DePhyneAI network. It serves multiple purposes:  Rewards: Earned by node operators who run AI tasks Access: Used to access AI models, data feeds, and services Governance: Voting and proposal mechanisms Staking: Ensures quality and uptime guarantees

DePhyneAI

DePhyneAI ($DPHYAI.X) is trending as part of the AI crypto wave, with community members actively discussing its potential within the Phantom wallet ecosystem. Some users are highlighting its microcap status and potential for growth, while others urge caution, referencing previous hyped tokens. The focus remains on $DPHYAI.X's role in the broader AI narrative within the crypto space.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins ($PENGU.X) is trending amid discussions about its potential for growth and comparisons to other meme coins like $DOGE.X. Community members are actively debating entry points, expressing both bullish sentiment and frustration with recent price action, while also anticipating potential catalysts like a PENGU ETF.

Cognizant Technology Solutions Corp. engages in providing information technology, consulting, and business process outsourcing services. Its services include application services, artificial intelligence, business process services, cloud solutions, and core modernization. It operates through the following segments: Financial Services (FS), Healthcare Sciences (HS), Products and Resources (P and R), and Communications, Media, and Technology (CMT). The FS segment focuses on banking and insurance services. The HS segment is involved in healthcare and life sciences. The P and R segment includes retail and consumer goods. The CMT segment relates to communications, information, media and entertainment, and technology. The company was founded by Wijeyaraj Kumar Mahadeva and Francisco D'Souza on April 6, 1988 and is headquartered in Teaneck, NJ.

Cognizant Technology Solutions Corp. - Ordinary Shares - Class A

Cognizant ($CTSH) is trending amid discussions about the potential impact of H-1B visa fee changes and wage rule revisions on its business. Some community members are weighing the impact of AI on the IT services sector, considering both short-term revenue compression and long-term opportunities for high-margin AI solutions. Recent analyst ratings and price target adjustments are also contributing to the stock's activity.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta ($KTA.X) is trending as the community anticipates the mainnet launch, with some speculating it could be a "sell the news" event while others remain optimistic. Discussions center around its potential to revolutionize finance and unify blockchains, comparing it to established players like XRP and ETH.  Enthusiasm is fueled by its high TPS and Google's involvement, with many seeing a long-term potential.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

Disney is trending due to controversy surrounding Jimmy Kimmel's show suspension, sparking intense debate about freedom of speech and potential political influence. The community is actively discussing boycotts and subscription cancellations, while others defend Disney's decision. Some see this as an opportunity for short-term gains, while long-term investors remain divided about the impact on Disney's brand and future.

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication; Energy, Utilities, Resources, and Services; Manufacturing, Hi-Tech, Life Sciences, and All Other. The company was founded by Dinesh Krishnan Swamy, Senapathy Gopalakrishnan, Narayana Ramarao Nagavara Murthy, Raghavan N. S., Ashok Arora, Nandan M. Nilekani, and S. D. Shibulal on July 2, 1981 and is headquartered in Bangalore, India.

Infosys Ltd - ADR

Infosys Technologies Limited

Infosys ($INFY) is trending due to discussions around potential impacts from new visa fee regulations and recent collaborations. The community is weighing the implications of a possible $100,000 H-1B visa fee on the company's margins and its reliance on Indian talent. At the same time, new partnerships, such as the one with Mastercard to scale cross-border payments, and a recent buyback announcement are also focal points for investors.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is trending due to its recent listing on major exchanges like Binance and Coinbase, sparking significant community excitement and high trading volume. Some users are drawing comparisons to other successful projects, such as $HYPE.X and $MYX.X, while highlighting the backing from prominent investors like Peter Thiel and Pantera Capital.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

FLGC is trending as community members discuss its potential, especially in relation to cannabis rescheduling and the company's crypto holdings. Some are speculating about upcoming revenue and potential for significant gains, while others are focused on compliance with Nasdaq listing standards and possible reverse splits. The stock's low float and recent news regarding funding and private placements are also driving interest.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma ($ALMU) is trending as investors discuss a recent stock offering and its potential impact on the company's future. Community members are debating whether the offering was a strategic move to secure funding for upcoming commercial deals, particularly in the defense and aerospace sectors. Bullish sentiment revolves around confidence in the company's technology and its potential to disrupt the semiconductor industry, while some express concern over dilution and the offering's price.

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

MiNK Therapeutics Inc

MiNK Therapeutics is trending due to the company's announcement of a grant-funded clinical trial for graft-versus-host disease and the appointment of Dr. Terese Hammond to lead inflammatory and pulmonary disease efforts. While some community members express skepticism, others are optimistic about the potential of iNKT cell therapies and the possibility of partnerships, leading to speculation about a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Altria Stock Trading at a Discount: What's the Next Best Move?

MO shows steady earnings and strong pricing power, though long-term momentum depends on balancing cigarette declines with smoke-free gains.

Here is What to Know Beyond Why Altria Group, Inc. (MO) is a Trending Stock

Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Altria Returns $4 Billion to Shareholders in First Half of 2025

MO has returned more than $4 billion to its shareholders in early 2025, fueled by strong dividends, buybacks and a solid balance sheet.

Altria (MO) Stock Slides as Market Rises: Facts to Know Before You Trade

Altria (MO) closed the most recent trading day at $64.84, moving 2.72% from the previous trading session.

Mo's Smoke-Free Vision vs. Cigarette Declines: Is Transition on Track?

Altria shows cigarette volumes sliding while on! nicotine pouches surge in the second quarter, spotlighting the gradual shift toward smoke-free growth.

Altria (MO) Stock Drops Despite Market Gains: Important Facts to Note

Altria (MO) closed at $65.79 in the latest trading session, marking a -1.15% move from the prior day.

The U.S. Food and Drug Administration (FDA) will launch a pilot program on Monday to fast-track reviews of nicotine pouches from four major tobacco companies, aiming to complete assessments by December under pressure from the Trump administration to speed approvals.The program will cover products from Philip Morris International, Altria, Reynolds American, part of British American Tobacco, and Turning Point Brands. Among them are PMI’s Zyn Ultra, Altria’s on! and on! Plus, Reynolds’ Velo mini, and Turning Point’s Fre and Alp, co-owned by former Fox News host Tucker Carlson, Reuters&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/us-fda-fast-track-nicotine-pouch-reviews-amid-white-house-pressure-2025-09-08/">reported</a>, citing FDA meeting transcripts.Nicotine pouch approvals have historically taken years. The FDA cleared its first group in January, including 20 Zyn products, more than five years after PMI first&nbsp;submitted its application.&nbsp;The pilot is expected to streamline reviews by focusing only on core product characterization, manufacturing, stability, and abuse-liability data, while increasing communication with companies.Nicotine pouches, placed under the lip, are the fastest-growing U.S. tobacco category, marketed as a lower-risk smoking alternative since they don’t involve inhalation or tobacco. Campaigners warn of youth appeal, while FDA officials say current data does not show significant youth uptake.PMI dominates the market with Zyn, which has posted 40% to 80% U.S. shipment growth every quarter since January 2023. Altria called the FDA’s new approach encouraging for harm reduction, while Turning Point Brands said it reflects a commitment to efficiency.&nbsp;An FDA official said the agency had been pressed by leadership, including the White House, to move faster. Tobacco firms have lobbied President Donald Trump for changes, with BAT’s Reynolds donating $10 million to a pro-Trump super PAC.Yolonda Richardson, CEO of the Campaign for Tobacco-Free Kids, said rigorous review remains essential: “There should be no shortcuts when it comes to our kids’ health.”On Stocktwits, retail sentiment was ‘neutral’ for Philip Morris and Turning Point Brands amid ‘normal’ message volume, while Altria saw ‘bearish’ sentiment with ‘low’ activity.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/PM">Philip Morris</a> shares are up 36.4%,&nbsp;<a href="https://stocktwits.com/symbol/MO">Altria</a> has gained 31.8%, and T<a href="https://stocktwits.com/symbol/TPB">urning Point Brands</a> has jumped 68.3%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Zyn nicotine pouches are advertised in Warsaw, Poland, April 2, 2025.

FDA To Rush Nicotine Pouch Approvals For Philip Morris, Altria And Turning Point After Trump Pressure

The pilot program will cover products such as PMI’s Zyn Ultra, Altria’s on! Plus, and Turning Point’s Fre, aiming to streamline reviews that previously took years.

Equity

Is Trending Stock Altria Group, Inc. (MO) a Buy Now?

Can on! Help Altria Capture More of the Booming Pouch Market?

MO's on! shipments jumped 26.5% in the second quarter, lifting its U.S. pouch share as marketing and earnings momentum intensify in a fast-growing market.

Altria (MO) Up 7.2% Since Last Earnings Report: Can It Continue?

Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

MO
Altria Group Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MO News

MO Altria Group Inc.